Keywords
SARS-CoV-2
ICU
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To discuss current knowledge about cardiovascular complications and outcomes triggered by COVID-19 in the ICU. Methods: For the integrative review, an advanced search for observational and interventional, quantitative and qualitative studies was used on PubMed and VHL platforms, with the following Health Sciences Descriptors (DeCS) in English: “Cardiovascular”, “COVID-19”, “Complication” and “Intensive Care Units”, interspersed by the boolean operator AND. Articles from 2019 to 2023, free of charge and in English and/or Portuguese were included, and those that deviated from the guiding question were excluded. Results: Among the 180 articles found, 15 met the defined criteria. A high prevalence of thromboembolic events, myocardial and vascular injuries was observed in thousands of patients with COVID-19 in ICU, with a direct relationship between the change in markers of cardiovascular disease in COVID-19 and poor prognosis, plus a “ripple effect” for new complications with each event. Final considerations: Given the exposed cardiovascular impact of COVID-19 in ICU patients, it is necessary to adopt evidence-based prophylactic measures, starting by epidemiological studies to clarify the occurrence of these events, followed by new prospective cohorts and clinical trials, in order to continuously evaluate these individuals and the interventions made.
References
BARDAJÍ A, et al. Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Revista española de Cardiologia. 2021; 74(1): 24-32.
BERG DD, et al. Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network. Journal of cardiac failure. 2022; 28(4): 675-681.
BILALOGLU S, et al. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020; 324(8): 799-801.
CHUNG MK, et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res. 2021; 128(8): 1214-1236.
CUCINOTTA D E VANELLI M. WHO Declares COVID-19 a Pandemic. Acta Biomédica. 2020; 91(1): 157-160.
GOSHUA G, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020; 7(8): 575-582.
GOMES BFO, et al. Impacto do Alto Risco Cardiovascular na Mortalidade Hospitalar em Pacientes Internados em Terapia Intensiva por COVID-19. Arquivos brasileiros de cardiologia. 2022; 118(5): 927-934.
HAMEED M, et al. Factors influencing international collaboration on the prevention of COVID-19. Elsevier Public Health Emergency Collection. 2022; 212: 95-101.
HAYEK SS, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. British Medical Journal. 2020; 371: e3513.
HOFFMANN M, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2): 271-280.
HUANG C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Elsevier Public Health Emergency Collection. 2020; 395 (10223): 497-506.
IMIG JD. SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection. Clin Sci (Lond). 2022; 136(6): 431-434.
JAIN, V, YUAN JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Nature Public Health Emergency Collection. 2020; 65(5): 533-546.
JOHN HOPKINS UNIVERSITY. 2023. In: COVID-19 Map. Baltimore: Coronavirus Resource Center. Disponível em: http://bit.ly/3ZXllNb. Acesso em: 15 jul. 2023.
LA VIA L, et al. Full and simplified assessment of left ventricular diastolic function in covid-19 patients admitted to ICU: Feasibility, incidence, and association with mortality. Echocardiography. 2022; 39(11): 1391-1400.
McCALL PJ, et al. Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia. 2022; 77(7): 772-784.
MEDATALIBEYOGLU A, et al. Cardiovascular view of intermediate and high-risk COVID-19 patients: single-centre experience with low mortality and intensive care hospitalization rates. Cardiovascular Journal of Africa. 2020; 32(2): 79-86.
PARASHER A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. BMJ Journals. 2021; 97(1147): 312-320.
PATEL U, et al. Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2021; 30(7): e105805.
POUW, N. et al. Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study. Plo S one. 2021; 16(3): e248713.
QIAN H, et al. Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study. J Cardiothorac Vasc Anesth. 2021; 35(3): 846-853.
RELLO J, et al. Update in COVID-2019 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Elsevier Public Health Emergency Collection. 2020; 39(6): 723-730.
SLUIS WM, et al. Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort Study. Stroke. 2021; 52(12): 3978-3986.
SULEMANE S, et al. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient. European Heart Journal. 2020; 115.
VASBINDER A, et al. Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19. Circulation: Cardiovascular quality and outcomes. 2020; 15(10): e8942.